Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating mirabegron for overactive bladder symptoms in men taking tamsulosin for lower urinary tract symptoms due to benign prostatic hyperplasi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Overactive Bladder

Drugs mentioned

• Myrbetriq (mirabegron)
• Tamsulosin hydrochloride (tamsulosin hydrochloride)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Benign Prostatic Hyperplasia, Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2019-10-02